Monte Rosa Therapeutics Ownership | Who Owns Monte Rosa Therapeutics?
Monte Rosa Therapeutics Ownership Summary
Monte Rosa Therapeutics is owned by 19.20% institutional investors, 0.72% insiders, and 80.08% retail investors. Nea management company is the largest institutional shareholder, holding 9.38% of GLUE shares. T. Rowe Price New Horizons is the top mutual fund, with 5.25% of its assets in Monte Rosa Therapeutics shares.
GLUE Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Monte Rosa Therapeutics | 19.20% | 0.72% | 80.08% |
| Sector | Healthcare Stocks | 279.19% | 10.58% | -189.76% |
| Industry | Biotech Stocks | 63.97% | 10.68% | 25.35% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Nea management company | 7.69M | 9.38% | $53.38M |
| Price t rowe associates inc /md/ | 7.12M | 8.68% | $49.39M |
| Versant venture management | 5.65M | 6.89% | $39.23M |
| Bvf inc/il | 5.66M | 6.89% | $26.26M |
| Fmr | 5.55M | 6.77% | $38.51M |
| Baker bros. advisors lp | 4.92M | 5.98% | $22.81M |
| Avoro capital advisors | 4.65M | 5.66% | $21.56M |
| Blackrock funding, inc. /de | 3.84M | 4.68% | $26.65M |
| Blackrock | 2.36M | 3.92% | $8.83M |
| Vanguard group | 3.16M | 3.85% | $21.91M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Versant venture management | 5.65M | 45.22% | $39.23M |
| Aisling capital management lp | 1.47M | 3.63% | $10.22M |
| Nea management company | 7.69M | 3.01% | $53.38M |
| Bvf inc/il | 5.66M | 1.07% | $26.26M |
| Alphabet | 1.46M | 0.59% | $10.16M |
| Suvretta capital management | 1.56M | 0.37% | $10.85M |
| Avoro capital advisors | 4.65M | 0.34% | $21.56M |
| Parkwood | 323.00K | 0.25% | $2.24M |
| Baker bros. advisors lp | 4.92M | 0.25% | $22.81M |
| Corton capital | 32.37K | 0.13% | $224.62K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Versant venture management | 5.65M | 45.22% | 5.65M |
| Bvf inc/il | 5.66M | 1.07% | 2.90M |
| Blackrock funding, inc. /de | 3.84M | 0.00% | 938.67K |
| Vanguard group | 3.16M | 0.00% | 622.13K |
| Price t rowe associates inc /md/ | 7.12M | 0.01% | 515.50K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Suvretta capital management | 1.56M | 0.37% | -1.10M |
| Vestal point capital, lp | - | - | -425.00K |
| Exoduspoint capital management, lp | - | - | -393.59K |
| Ikarian capital | 136.57K | 0.08% | -175.00K |
| Jump financial | - | - | -154.84K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Versant venture management | 5.65M | 45.22% | 5.65M | $39.23M |
| Norges bank | 445.87K | 0.00% | 445.87K | $3.09M |
| Quest partners | 94.63K | 0.09% | 94.63K | $656.75K |
| Corton capital | 32.37K | 0.13% | 32.37K | $224.62K |
| Franklin resources | 27.51K | 0.00% | 27.51K | $190.92K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -6.00 |
| Us bancorp \de\ | -26.00 |
| Capital performance advisors llp | -29.00 |
| Point72 asset management | -250.00 |
| Toronto dominion bank | -800.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 6 | -94.44% | 15,774,831 | -74.13% | 19 | 0.35% | 3 | -95.77% | 1 | -94.12% |
| Dec 31, 2024 | 55 | -34.52% | 25,603,232 | -48.56% | 31 | 0.85% | 40 | -25.93% | 4 | -66.67% |
| Sep 30, 2024 | 84 | 9.09% | 49,773,785 | 8.59% | 60 | 1.47% | 54 | 14.89% | 12 | - |
| Jun 30, 2024 | 76 | 7.04% | 45,836,354 | 14.90% | 76 | 1.26% | 47 | 62.07% | 12 | -47.83% |
| Mar 31, 2024 | 71 | -10.13% | 39,892,663 | -0.52% | 77 | 1.20% | 29 | 3.57% | 23 | -11.54% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| T. Rowe Price New Horizons | 3.23M | 5.25% | -175.14K |
| US Small-Cap Growth II Equity Comp | 3.23M | 5.25% | -176.12K |
| Vanguard Total Stock Mkt Idx Inv | 1.92M | 3.12% | - |
| Fidelity Growth Compy Commingled Pl S | 1.59M | 2.58% | - |
| HBM Healthcare Investments AG Ord | 1.41M | 2.29% | - |
| iShares Russell 2000 ETF | 1.05M | 1.71% | 513.00 |
| T. Rowe Price Health Sciences | 1.01M | 1.64% | -15.27K |
| Fidelity Growth Company Fund | 976.17K | 1.59% | - |
| Fidelity Growth Compy Commingled Pl O | 970.82K | 1.58% | - |
| T. Rowe Price New Horizons Tr-Z | 887.19K | 1.44% | 1.28K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 03, 2025 | Dunn Edmund | Principal Accounting Officer | Sell | $9.17K |
| Mar 24, 2025 | Leo Chandra P. | - | Buy | $58.38K |
| Oct 29, 2024 | Versant Venture Capital VI, L.P. | - | Sell | $146.79K |
| Oct 28, 2024 | Versant Venture Capital VI, L.P. | - | Sell | $869.24K |
| Oct 29, 2024 | Versant Venture Capital VI, L.P. | - | Sell | $475.01K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | 1 |
| 2025 Q1 | 1 | - |
| 2024 Q4 | - | 3 |
| 2024 Q3 | - | 5 |
| 2024 Q2 | - | 1 |
GLUE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools